Zeev Bronfeld - Director at Protalix BioTherapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
PLX on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Zeev Bronfeld since 18 Oct 2025

Reported holdings for Zeev Bronfeld in Protalix BioTherapeutics, Inc.

Form 4 holding Director

Protalix BioTherapeutics, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
100,000
Estimated value
Report date
07 Sep 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Zeev Bronfeld in Protalix BioTherapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .